Who Owns Extendicare Company?

Extendicare Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Controls Extendicare?

The trajectory of Extendicare, a prominent player in Canada's senior care landscape, has been shaped by a fascinating evolution in its ownership structure. From its origins as Pendexcare Ltd. to its current status, the company's journey reflects strategic shifts and pivotal decisions. Understanding Extendicare SWOT Analysis is key to grasping the company's position.

Extendicare's transition from an income trust to a corporate structure in 2012 marked a significant turning point, influencing its strategic direction and shareholder value. This exploration into Extendicare ownership will uncover the key players, from the founders' initial vision to the influence of major shareholders and the impact of being Extendicare publicly traded. Analyzing Who owns Extendicare provides crucial insights into the company's future in the dynamic Extendicare healthcare sector, including its Extendicare facilities and overall performance.

The roots of Extendicare, a significant player in the healthcare sector, trace back to 1968. It was founded by Harold Livergant and John MacKay, who envisioned a company dedicated to enhancing the quality of care for seniors. This commitment to senior care has been a constant throughout the company's history.

Initially named Pendexcare Ltd., the company's early focus was on providing long-term care services. This aimed to alleviate the strain on Canada's hospital system. Shortly after its founding, the name was changed to Extendicare (Canada) Ltd., and it later evolved into Extendicare Inc.

The specific details regarding the initial equity split or shareholding percentages of Harold Livergant and John MacKay at the company's inception aren't available in the provided information. Information about early investors, angel investors, or family members who acquired stakes in the initial phase is also not available. The founding team's vision for quality seniors' care has remained central to Extendicare's operations as it grew from its first nursing home in Ottawa in 1969.

Early Ownership and Evolution

The founders, Harold Livergant and John MacKay, laid the groundwork for what would become a major healthcare provider. The company's initial focus was on long-term care, evolving from Pendexcare Ltd. to Extendicare (Canada) Ltd., and eventually, Extendicare Inc. The company's early growth was marked by its first nursing home in Ottawa in 1969, reflecting its commitment to providing care.

• The company's early focus was on long-term care services.
• The company's name changed multiple times.
• The founders' vision has remained central to Extendicare's operations.
• Extendicare's first nursing home opened in Ottawa in 1969.

Extendicare SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership structure of Extendicare has seen notable changes since its inception. Initially, the company operated as a corporation. In 2006, it transitioned into a real estate investment trust (REIT), trading on the Toronto Stock Exchange (TSX) under the symbol EXE.UN. This shift aimed to optimize business risk and return alignment. However, in 2012, Extendicare reverted to a corporate structure, now known as Extendicare Inc., a move designed to offer shareholders improved liquidity.

These structural adjustments reflect the company's strategic responses to market dynamics, capital needs, and expansion goals. The conversion to a REIT and back to a corporate structure, along with the establishment of joint ventures, highlight Extendicare's efforts to adapt and grow within the healthcare sector. The company's evolution underscores its commitment to navigating the complexities of the healthcare market and maximizing shareholder value.

As a publicly traded entity on the TSX (TSX: EXE), Extendicare's ownership is spread among various shareholders. As of February 26, 2025, the company had 83,467,000 common shares issued and outstanding. Institutional investors hold a significant portion of the shares. For instance, as of June 10, 2024, Extendicare Inc. (OTCPK:EXETF) had 32 institutional owners, collectively holding 1,760,150 shares. Key institutional shareholders include DFA INVESTMENT TRUST CO and iShares Core MSCI Total International Stock ETF. Moreover, individual insiders, such as CEO Michael Guerriere, also maintain stakes in the company, owning 0.4% of the shares as of March 2025, valued at approximately CA$4.78 million.

Key Ownership Highlights

Extendicare's ownership structure has evolved significantly, impacting its strategic direction and financial performance. The company's conversion to and from a REIT, along with the establishment of joint ventures, demonstrates its adaptability. Understanding the ownership dynamics is crucial for investors and stakeholders interested in Extendicare and its future. For more insights into Extendicare's strategic initiatives, see Growth Strategy of Extendicare.

• Publicly traded on the TSX under the symbol EXE.
• Institutional investors hold a significant portion of the shares.
• CEO Michael Guerriere owns a stake in the company.
• The company has joint ventures with Axium Extendicare LTC II LP and Axium Extendicare LTC LP.

Extendicare PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of April 17, 2025, the board of directors of Extendicare consists of nine members. This board is responsible for overseeing the company's business and affairs, including financial and strategic planning. Directors are elected by shareholders at the annual meeting, serving until the next annual meeting. The current CEO, Dr. Michael R. Guerriere, is also a director. Other key individuals in leadership roles include David Bacon (Executive Vice President and CFO), Joe Belinsky, Katie LeMoyne, Steve Paraskevopoulos, and John Toffoletto.

As of February 27, 2025, Donald Clow and Heather-Anne Irwin joined the board, with Al Mawani retiring after seven years. The average tenure of the board members is approximately 7.3 years. This composition and the experience of the directors are critical to guiding Extendicare's strategic direction and ensuring effective governance. Understanding the board's structure provides insight into the decision-making processes and the influence of key stakeholders within the Extendicare company.

Extendicare ownership structure grants each shareholder one vote per common share. There are no special voting rights that would give outsized control to specific entities. In May 2020, Sandpiper Group increased its stake to approximately 10.01% of outstanding shares. Samir Manji, CEO of Sandpiper Group, was also a board member in 2020, illustrating a direct link between major shareholders and board representation. At the May 27, 2025, shareholder meeting, 56.41% of outstanding shares were represented, with shareholders approving the election of directors and executive compensation. For more insights, you can explore the Marketing Strategy of Extendicare.

Board of Directors and Voting Power

Extendicare's board of directors oversees the company's strategic direction. The voting structure is one-share-one-vote, ensuring equitable shareholder influence. Key shareholders, like Sandpiper Group, have board representation, influencing governance.

• Nine directors currently serve on the board.
• Shareholders actively participate in governance.
• Extendicare's governance structure is transparent.
• The board's average tenure is 7.3 years.

Extendicare Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, Extendicare has been actively involved in strategic initiatives that have significantly impacted its ownership profile. The company's focus has been on expanding its long-term care and home healthcare services through acquisitions, joint ventures, and property transactions. This strategic shift is evident in the company's recent moves to acquire and develop new facilities, indicating a dynamic approach to its market position and ownership structure. Extendicare's actions reflect a broader trend in the healthcare sector towards consolidation and strategic partnerships.

In November 2024, announced an agreement to acquire nine long-term care homes from Revera Inc. for approximately $60.3 million, adding 1,396 beds to its portfolio. This acquisition is expected to generate approximately $124.0 million in annualized revenue for Extendicare's Long-Term Care (LTC) segment. Additionally, the company is involved in several redevelopment projects, with six LTC projects under construction in Ontario as of February 2025, which will introduce 1,408 new beds. These activities are part of Extendicare's strategy to enhance its service offerings and expand its market presence.

Extendicare's financial strategy includes share management and capital restructuring. The company renewed its normal course issuer bid (NCIB) in June 2024, allowing it to repurchase up to 7,159,997 common shares until July 1, 2025. It completed the redemption of its 2025 convertible debentures in December 2024, utilizing a new $275.0 million senior secured credit facility. As of March 31, 2025, Extendicare reported strong liquidity with $109.5 million in cash and $108.5 million available under its credit facility. Furthermore, the company increased its monthly dividend by 5.0% to $0.042 per share, effective March 2025, reflecting its commitment to returning value to shareholders.

Acquisition Strategy

Extendicare is actively acquiring long-term care facilities and home healthcare services to expand its market presence. This includes the recent acquisition of nine LTC homes from Revera and an agreement to acquire Closing the Gap Healthcare.

Financial Performance

The company's financial performance includes strong liquidity with $109.5 million in cash and a $275.0 million senior secured credit facility. Extendicare also increased its monthly dividend by 5.0% to $0.042 per share.

Shareholder Value

Extendicare is returning value to shareholders through dividends and share buybacks. The company renewed its normal course issuer bid and increased its dividend, demonstrating its commitment to shareholder returns.

Strategic Partnerships

Extendicare is leveraging joint ventures and strategic acquisitions to drive growth. The Axium Joint Venture is a key example, with new homes opening in Kingston and Stittsville, replacing older facilities.

Extendicare Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs